Clatterbridge Centre for Oncology

Similar documents
Syringe driver in Palliative Care

Syringe Drivers. Back to top

SYRINGE DRIVER MEDICATIONS

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice

Algorithms for Symptom Management. In End of Life Care

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

End of life prescribing guidance

Renal Palliative Care Last Days of Life

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

Supportive Care. End of Life Phase

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

Using syringe pumps in palliative care

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

Symptom Management Guidelines for End of Life Care

Renal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life

Guidelines for Syringe Driver Management in Palliative Care in New Zealand

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1

Care in the Last Days of Life

End Stage Liver Disease Regional Audit Casenote Survey

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

The last days of life in hospital and at home

ADULT SYRINGE DRIVER PROTOCOL (T34)

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents:

MND Just in Case kit Information for GPs

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

Care of dying adults in the last days of life. Improving care at the very end of life.

Conservative Management of Uraemia

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon

Controlling nausea and vomiting: anti-emetic therapy advice

McKinley T34 Syringe Pump Policy and Procedure

Planning for the future; A guide to symptom control at end of life in advanced dementia

Eastern Health and Social Services Board Palliative Care

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

What else is new (other symptoms) DR ANDREW DAVIES

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:

Care of the Dying Management in Severe Renal Failure

Isle of Wight Syringe Driver Compatibility Guidelines

First published in 2006 as Guidelines for syringe driver management in palliative care. Reprinted 2007

Care of the Dying Management in Severe Renal Failure

POLICY / PROCEDURE FOR THE USE OF THE McKinley T34 SYRINGE DRIVER

Syringe Pumps: Guidance for the use with babies, children and young people in the community setting within Worcestershire

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110

Palliative care for heart failure patients. Susan Addie

Lothian Palliative Care Guidelines POCKET EDITION 2004

Palliative Care. Guidelines for prescribing analgesic in palliative care THREE PRESCRIBING IN PALLIATIVE CARE GUIDELINES FOR MANAGING COMMON SYMPTOMS

BACKGROUND Measuring renal function :

Palliative Care. Pocketbook 4

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

Use of the Graseby MS26 Syringe Driver For Palliative Care Within West Lothian

Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist

Alternative Routes of Drug Administration (analgesia) Dr Andrew Dickman Consultant Pharmacist

Palliative Care Impact Survey

Palliative Care Formulary

Understanding pain in 5 minutes

This survey aims to look at individual practice and can be completed by any healthcare professional.

Access to Palliative Care Drugs and Advice through Lothian Primary Care NHS Trust Community Pharmacy Palliative Care Network

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

Adult Palliative and Supportive Care: Ambulatory Syringe Pump Policy including Symptom Management Guidelines

Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital.

Palliative care for patients with brain cancer

Palliative Care. Anticipatory Prescribing Guidelines & June Gippsland Region Palliative Care Consortium Clinical Practice Group

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

Yorkshire Cancer Network

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

PRIMARY CARE PALLIATIVE CARE FORMULARY

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

Symptom Management in the last weeks & days of life. Facilitator: Vernon Davis RN/Community Team Leader Rowcroft Community Team

Pain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017

What s New 2003? What new treatments? What have you discontinued? More information please!

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC)

Palliative Prescribing - Pain

Palliative Care Emergencies. Additional module if needed

Implementing the recommendation on medication management and symptom control

West Midlands Palliative Care Physicians. Palliative care. Guidelines for the use of drugs in symptom control

DRUG COMBINATIONS IN PALLIATIVE CARE: A COMPATIBILITY STUDY

In our patients the cause of seizures can be broadly divided into structural and systemic causes.

1. Diagnosing and treating pain

PRIMARY CARE PALLIATIVE CARE FORMULARY

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Administration of Drugs via the CME Medical T34 Syringe Driver Standard Operating Procedure

Syringe drivers. *precipitation may be seen at higher doses

SCHEDULE 2 THE SERVICES

Adult Palliative and Supportive Care: Ambulatory Syringe Driver Policy (including Symptom Management Guidelines)


Treating the symptoms of kidney failure

BJF Acute Pain Team Formulary Group

Transcription:

Clatterbridge Centre for Oncology

CONTENTS 1. Why and when to use a syringe driver 2. Siting the syringe driver 3. Mixing and measuring 4. Setting up the syringe driver 5. Drug information 6. Common problems & mistakes 7. Practical assessments 8. Useful reading 9. Quiz

WHY AND WHEN TO USE A SYRINGE DRIVER Give some situations where you might use a syringe driver

Your answers should have included: Any situation where medication can t be taken orally, rectally or is ineffective e.g. Persistent nausea and vomiting Severe dysphagia Malabsorbtion of drugs Intestinal obstruction Semi-comatose state/unconsciousness Too weak for oral drugs e.g shortly before death Non-compliant with oral medication/inability to take oral medication Contraindications/Considerations: Thrombocytopenia Metal allergy Plaster allergy Patient/family choice

SITING THE SYRINGE DRIVER The commonest choices for infusion sites are (mark them on the diagram)

Your answers should have included Upper chest Upper/outer arm Abdomen Thighs Avoid areas where there may be an increased risk of malabsorption of the drugs such as: Areas of oedema or lymphoedema Particularly cachectic areas i.e. little tissue to inject into

If the infusion causes pain or local irritation what actions would you consider taking?

Your answers should have included - Changing the site daily Changing to a non-metal needle Reducing the quantity of or consider an alternative to any irritant drugs Increasing the dilution of the solution using a larger syringe Injecting hyaluronidase 1500 units into the site first

MIXING AND MEASURING As a general rule sterile water should be used for mixing the drugs that go into a syringe driver. Some drugs will need to be mixed with sterile normal saline (as per guidelines), if not there is a risk of crystallisation of the contents of the syringe. Setting the Rate At Clatterbridge Centre for Oncology, Graseby MS26 syringe drivers are used. To set the rate for this type of syringe driver measure the length of the liquid in the barrel of the syringe in millimetres. The length in millimetres is therefore the rate that is set on the side of the syringe driver no maths required! If this is a new infusion, prime the line first, then measure the barrel of the syringe Measure the syringe each time the infusion is changed e.g. length of barrel = 48mm: set the rate to 48mm in 24hours. In other words the plunger in the syringe will take 24 hours to travel 48mm.

SETTING UP THE SYRINGE DRIVER 1. Insert the battery, the alarm will sound (press the boost button to silence). Each battery should last for about 50 full syringes. The light will flash every 30 seconds, but will stop flashing 24 hours before the battery runs out. 2. Fit the finger grip of the syringe into the slot provided 3. Secure the syringe with the rubber strap 4. Press the white button on the actuator and slide along until firmly against the syringe plunger 5. Press the boost button once 6. Place the syringe driver in the plastic holder and protect from light 7. Check the syringe, syringe driver and injection site at least every 4 hours

Diamorphine DRUG INFORMATION 5mg - there is no maximum dose Analgesic of choice as it is highly soluble. S/C diamorphine is 3 times stronger than oral morphine e.g MST 60mg BD +30mg of oramorph = 150mg of oral morphine in 24 hours this would mean 50mg of S/C diamorphine in 24 hours. Always ensure that a PRN dose of diamorphine is available for breakthrough pain, this should be 1/6 of the 24 hours dose. e.g diamorphine 30mg/24hours needs 5mg of diamorphine S/C available PRN. Cyclizine (Valoid) Used for: nausea and vomiting 50-150mg/24hours Available as: 50mg/ml Notes: mix only with water may precipitate with diamorphine useful in intestinal obstruction Clonazepam (Rivotril) Used for: terminal restlessness, myclonus and neuropathic pain 2-4mg/24hours Available as: 1mg/2ml

Dexamethasone (Decadron) Used for: raised intracranial pressure, pain caused by nerve compression, nausea and vomiting 8-16mg/24hours Available as: 8mg/2ml Notes: use a separate syringe driver as high risk of precipitation if mixed with other drugs Haloperidol (Haldol) Used for: nausea and vomiting, sedation in higher doses 2.5-15mg/24hours Available as: 5mg/ml Notes: useful for hiccups as well as drug induced nausea and vomiting Glycopyrronium (Robinul) Used for: reduction of respiratory secretions 800-2400mcg/24hours Available as: 600mcg/3ml Notes: less sedating than hyoscine hydrobromide Hyoscine Hydrobromide Used for: reduction of respiratory secretions 400-2400mcg/24hours Available as: 400mcg/ml Notes: also has a small antiemetic and sedative effect

Hyoscine Butylbromide (Buscopan) Used for: colic/spasmodic pain 20-60mg/24hours Available as: 20mg/ml Notes: useful for colic from intestinal obstruction may crystallise with cyclizine Levomepromazine (Nozinan) Used for: nausea and vomiting, sedation, pain 5-25mg/24hours antiemetic 25-150mg/24hours sedative Available as: 25mg/ml Notes: may cause site irritation can be mixed with saline or water above 15mg can have an analgesic effect Metoclopramide (Maxalon) Used for: nausea and vomiting 30-60mg/24hours Available as: 10mg/2ml Notes: works by increasing gut motility therefor do not use in intestinal obstruction can cause irritation at the injection site Midazolam (Hypnovel) Used for: sedation 10-100mg/24hours Available as: 10mg/2ml Notes: useful for anxiety, agitation, muscle spasm and as an anticonvulsant

Octreotide (Sandostatin) Used for: reducing gastric secretions 300-600mcg/24hours Available as: 50mcg/ml; 100mcg/ml; 500mcg/ml Notes: will reduce the size and frequency of vomits in gastric and intestinal obstruction will precipitate when mixed with cyclizine Ondansetron (Zofran) Used for: nausea and vomiting 8-24mg/24hours Available as: 4mg/2ml; 8mg/4ml Notes: useful for nausea and vomiting caused by radiotherapy or chemotherapy dilute with saline

COMMON PROBLEMS & MISTAKES The injection site appears sore and inflamed Some drugs (particularly cyclizine and levomepromazine) can cause soreness and inflammation. Alternatively it can be caused by a reaction to the needle itself. What would you consider doing about this?

Your answers should have included: Changing the injection site regularly i.e. every 24 48 hrs Increase the dilution of the infusion i.e. by using a 20 or 30ml syringe Use a teflon needle rather than a metal one Inject 1500u of hyaluronidase into the site first Change to a less irritant drug combination

The infusion is finishing in less than 24 hours What could be the possible causes of this?

Your answer should have included: That this can be due to either: the infusion not being measured correctly when setting the rate or regular use of the boost button on the syringe driver. Pressing the boost button once will move the syringe forward 0.23mm. In a 10ml syringe with 30mg of diamorphine this means a dose of 0.3mg would need up to 5 boosts! Ask the doctor to prescribe a dose of diamorphine s/c for breakthrough pain, this should usually be 1 sixth o the 24-hour dose.

The infusion takes more than 24 hours What could be the possible causes of this?

Your answers should have included: An incorrect rate The syringe driver light isn t flashing The syringe isn t site into the driver correctly The battery needs replacing The syringe needs changing due to crystallisation The injection site looks sore, red or lumpy. You may need to change the site Has the infusion been stopped at all for any reason?

PRACTICAL ASSESSMENTS Date/Assessors Initials Safely Mix Drugs & Diluent Correctly Set Up Line, Needle & Syringe Correctly Set Rate of the Syringe Driver Correctly Site the Needle Correctly Start the Syringe Driver Able to Discuss Why the Current Drugs Are Being Used

USEFUL READING Drug Information Letter No.117: Palliative Care Prescribing North West Medicines Information Centre January 2001 Palliative Care Formulary 1 1998 Twycross, Wilcock & Thorp The Syringe Driver In Palliative Care Andrew Dickman & Clare Littlewood, St.Helens & Knowsley Hospitals 1998

Quiz You re going to mark this yourself, so don t cheat! 1. If in doubt mix with what solution? 2. Which is the analgesic that is most commonly used in syringe drivers and why? 3. Name 2 sedating antiemetics.

4. Name a non-sedating antiemetic. 5. Hyoscine butylbromide is used for treating what? 6. Hyoscine hydrobromide is used for treating what? 7. Which 2 drugs are useful for reducing respiratory secretions?

8. How would you deal with an infusion that has crystallised? 9. Your patient has a red/inflamed injection site, what steps would you take to minimise the risk of this happening again? 10.What is the boost button for?